ZBTB17 and lymphoma: In 3T9MYC-ER cells and Eμ-myc lymphomas, instead, the MYC share had much stronger predictive values, with minor albeit significant contributions of ZBTB17—whether expressed as a MYC/ZBTB17 ratio or as straight ZBTB17 binding (Supplemental Fig. S1E).